I’m really excited to share that the new medical textbook I authored is now available. I’m excited to continue this lifelong journey of learning and translating the complexities of medicine into an accessible educational resource for years to come. #mcgrawhill#hospitalmedicine
The third episode I was an expert discussant on the Harrison’s PodClass aired today, Episode 204: A 72-Year-Old with Worsening Exertional Dyspnea. I hope you enjoy! https://t.co/23AAfcyAeX
The second of three podcast episodes I was the expert discussant on aired today: A 42-Year-Old with Cirrhosis. It was a pleasure working with Dr. Handy Marshall and Dr. Wiener on this podcast, they were so warm and welcoming. https://t.co/8uR6jWbfSr #InternalMedicine#McGrawHill
I was lucky enough to be an expert discussant on the Harrison’s PodClass for three episodes. The first episode, A 68-Year-Old with Acute Abdominal pain, aired today. https://t.co/Nowhm95XNH
Case from tonight: 50 yo m with myeloma admitted 3 days ago for cyclophosphamide. HR now 150’s. Image 1 show initial rhythm. Image 2 shows after a medication was given. What medication was administered?
Correct answer: B) sacubitril/valsartan. The PARAGLIDE-HF trial saw significantly lower BNP levels compared to valsartan alone and a trend towards clinical outcome improvements. This has lead to a recommendation of Entresto being considered for patients with HFpEF with an EF <60%
Which of the following therapies for a patient with HFpEF (EF 55%) reduces BNP levels compared to valsartan?
A) metoprolol succinate
B) lisinopril
C) sacubitril/valsartan
D) digoxin
#meded#IM#cardiology#InternalMedicine
Well, the one person who voted got it right! Only a CT head (to rule out intracranial hemorrhage) and POC glucose (to rule out hypoglycemia causing stroke like symptoms) are required prior to IV thrombolysis for the management of ischemic stroke.